1 / 4

Asia-Pacific Inflammatory Bowel Disease (IBD) Therapeutics Market Growth, Size, Share, Industry Report and Forecast 2019

Asia-Pacific IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.5% during the forecast period. The major economies which are contributing to the market are China, India, and Japan. The market growth in these countries is mainly attributed to the growing healthcare infrastructure due to substantial government spending in the healthcare sector.

mansi3210
Télécharger la présentation

Asia-Pacific Inflammatory Bowel Disease (IBD) Therapeutics Market Growth, Size, Share, Industry Report and Forecast 2019

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Asia-Pacific Inflammatory Bowel Disease (IBD) Therapeutics Market, Size, Share, Analysis Report & Forecast to 2025 Request a Free Sample of our Asia-Pacific Inflammatory Bowel Disease (IBD) Therapeutics Market: https://www.omrglobal.com/request-sample/asia-pacific-ibd-inflammatory-bowel-disease- therapeutics-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

  2. Asia-Pacific IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.5% during the forecast period. The major economies which are contributing to the market are China, India, and Japan. The market growth in these countries is mainly attributed to the growing healthcare infrastructure due to substantial government spending in the healthcare sector. Rapid urbanization and changing eating habits are also supposed to grow the market substantially in the region. Japan contributes significantly to the IBD market in the Asia-Pacific due to growing awareness about IBD and the established healthcare industry. Along with these economies, Australia, Indonesia, and Thailand are other major regions with advanced healthcare facilities and will show a significant growth rate during the forecasted period. A full Report of Asia-Pacific Inflammatory Bowel Disease (IBD) Therapeutics Market is Available at: https://www.omrglobal.com/industry-reports/asia-pacific-ibd-inflammatory-bowel-disease- therapeutics-market Asia-Pacific IBD therapeutics market is segmented on the basis of disease type and treatment type. The disease type segment includes ulcerative colitis and Crohn’s disease. Crohn’s disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn’s disease than ulcerative colitis. For Crohn’s and ulcerative colitis, the development of minimally invasive methods has been evolved with more caution as compared to other colorectal diseases. This is primarily due to disease-related characteristics that are concerned with IBD. The treatment type segment is further segmented into anti-inflammatory drugs and surgery. There is a range of anti-inflammatory drugs used for the treatment of IBD, such as immunosuppressants (methotrexate, ciclosporin, and azathioprine), steroids and biological drugs. These are usually the first step in the treatment of IBD. Request a Free Sample of our Asia-Pacific Inflammatory Bowel Disease (IBD) Therapeutics Market: https://www.omrglobal.com/request-sample/asia-pacific-ibd-inflammatory-bowel-disease- therapeutics-market Asia-Pacific Inflammatory Bowel Disease IBD Therapeutics Market Segmentation By Disease Type •Ulcerative Colitis •Crohn’s Disease By Treatment Type •Surgery •Anti- Inflammatory Drug Administration •Steroids •Immunosuppressant

  3. •Biological Drugs •Amino salicylates •Others Regional Analysis •China •India •Japan •Rest of Asia-Pacific Company Profiles •AbbVie Inc. •Allergan, PLC •Boehringer Ingelheim International GmbH •Daiichi Sankyo Co. Ltd. •Eli Lilly and Co. •Johnson & Johnson Services Inc. •Mercator Pharmaceutical Solutions •Pfizer Inc. •RPG Life Sciences Ltd. •Sanofi S.A. •Takeda Pharmaceutical Co., Ltd. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/asia-pacific-ibd-inflammatory-bowel-disease-therapeutics-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

More Related